LGALS3BP AS A DIAGNOSTIC, PROGNOSTIC, AND THERAPEUTIC BIOMARKER IN COVID-19 AND OTHER… Application WO-2022096732-A1 World Intellectual Property Organisation (WIPO) 12 May 2022
LGALS3BP AS A DIAGNOSTIC, PROGNOSTIC, AND THERAPEUTIC BIOMARKER IN COVID-19 AND OTHER… Application EP-3995829-A1 European Patent Office 11 May 2022
LGALS3BP ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER Application WO-2019197651-A1 World Intellectual Property Organisation (WIPO) 17 Oct 2019